These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 34547092)
21. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants. Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181 [TBL] [Abstract][Full Text] [Related]
22. Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose. Terpos E; Trougakos IP; Gavriatopoulou M; Papassotiriou I; Sklirou AD; Ntanasis-Stathopoulos I; Papanagnou ED; Fotiou D; Kastritis E; Dimopoulos MA Blood; 2021 Jul; 137(26):3674-3676. PubMed ID: 33861315 [No Abstract] [Full Text] [Related]
23. SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients. Deng Y; Li Y; Yang R; Tan W Cell Mol Immunol; 2021 Aug; 18(8):2040-2041. PubMed ID: 34267334 [No Abstract] [Full Text] [Related]
24. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine. Krammer F; Srivastava K; Alshammary H; Amoako AA; Awawda MH; Beach KF; Bermúdez-González MC; Bielak DA; Carreño JM; Chernet RL; Eaker LQ; Ferreri ED; Floda DL; Gleason CR; Hamburger JZ; Jiang K; Kleiner G; Jurczyszak D; Matthews JC; Mendez WA; Nabeel I; Mulder LCF; Raskin AJ; Russo KT; Salimbangon AT; Saksena M; Shin AS; Singh G; Sominsky LA; Stadlbauer D; Wajnberg A; Simon V N Engl J Med; 2021 Apr; 384(14):1372-1374. PubMed ID: 33691060 [No Abstract] [Full Text] [Related]
25. Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19. Joob B; Wiwanitkit V Clin Appl Thromb Hemost; 2021; 27():10760296211020833. PubMed ID: 34142570 [No Abstract] [Full Text] [Related]
26. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675 [TBL] [Abstract][Full Text] [Related]
27. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection. Li M; Guo J; Lu S; Zhou R; Shi H; Shi X; Cheng L; Liang Q; Liu H; Wang P; Wang N; Wang Y; Fu L; Xing M; Wang R; Ju B; Liu L; Lau SY; Jia W; Tong X; Yuan L; Guo Y; Qi H; Zhang Q; Huang Z; Chen H; Zhang Z; Chen Z; Peng X; Zhou D; Zhang L Front Immunol; 2021; 12():697074. PubMed ID: 34262569 [TBL] [Abstract][Full Text] [Related]
29. Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix. Di Giacomo AM; Giacobini G; Gandolfo C; Lofiego MF; Cusi MG; Maio M Eur J Cancer; 2021 Oct; 156():119-121. PubMed ID: 34428684 [No Abstract] [Full Text] [Related]
30. Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines. Abbasi J JAMA; 2021 Aug; 326(7):589-590. PubMed ID: 34319350 [No Abstract] [Full Text] [Related]
31. Confronting the Delta Variant of SARS-CoV-2, Summer 2021. Del Rio C; Malani PN; Omer SB JAMA; 2021 Sep; 326(11):1001-1002. PubMed ID: 34406361 [No Abstract] [Full Text] [Related]
32. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays. Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306 [TBL] [Abstract][Full Text] [Related]
33. Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration. Yi SG; Knight RJ; Graviss EA; Moore LW; Nguyen DT; Ghobrial RM; Gaber AO; Huang HJ Transplantation; 2021 Jul; 105(7):e72-e73. PubMed ID: 33741844 [No Abstract] [Full Text] [Related]
34. No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination. Uzun G; Althaus K; Bakchoul T N Engl J Med; 2021 Sep; 385(14):1334-1336. PubMed ID: 34432977 [No Abstract] [Full Text] [Related]
35. Case Builds for Booster Shots for People with Cancer. Cancer Discov; 2022 Jan; 12(1):7. PubMed ID: 34764194 [TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn. Connors M; Graham BS; Lane HC; Fauci AS Ann Intern Med; 2021 May; 174(5):687-690. PubMed ID: 33460347 [TBL] [Abstract][Full Text] [Related]
37. A French cohort for assessing COVID-19 vaccine responses in specific populations. Loubet P; Wittkop L; Tartour E; Parfait B; Barrou B; Blay JY; Hourmant M; Lachâtre M; Laplaud DA; Laville M; Laviolle B; Lelievre JD; Morel J; Nguyen S; Spano JP; Terrier B; Thiebaut A; Viallard JF; Vrtovsnik F; de Lamballerie X; Launay O Nat Med; 2021 Aug; 27(8):1319-1321. PubMed ID: 34253930 [No Abstract] [Full Text] [Related]